Recipharm announces its new blow-fill-seal machinery is now operational following an investment last year at its facility in Kaysersberg, France.
The EUR 18 million investment adds a new blow-fill-seal high-speed filling and packaging line to the site, taking the total number of lines to eight and increasing the facility’s manufacturing capacity by 200 million unidoses/year.
In addition, the investment adds 2,400 square meters to the facility creating space for a further three machines, which will ultimately allow the site to manufacture over 1.2 billion unidoses/year.
“This latest investment is in direct response to customer demand for single-dose and sterile manufacturing services, such as aseptic processing for eye care and ear care products, particularly from markets such as the US, Turkey, Australia and Canada,” Yves Buelens, General Manager at Recipharm’s Kaysersberg site, said. “This project was supported by the Region Grand Est and the CCI Alsace Eurométropole as part of employment-related actions”.
The Kaysersberg site, located in Alsace, France, is a facility specializing in Blow-fill-seal technology for sterile liquids. The site manufactures single dose units and has an advanced aseptic process for sterile liquid packaging applications.